Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

CStone Pharmaceuticals Director's Dealing 2022

Aug 8, 2022

50715_rns_2022-08-08_4b765bdf-dff7-4d4a-8326-7fa29419e922.pdf

Director's Dealing

Open in viewer

Opens in your device viewer

==> picture [173 x 58] intentionally omitted <==

Public Disclosure Form

8 August 2022

Possible offer

Disclosure of dealings in the shares of Yankuang Energy Group Company Limited

The Executive received the following disclosure of securities dealings pursuant to Rule 22 of the Hong Kong Code on Takeovers and Mergers:

Party Date Description
of relevant
securities
Nature of dealings Purchase
/ Sale
Total
number of
shares
involved
Total amount
paid / received
Highest (H)
prices paid
/ received
Lowest (L)
prices paid
/ received
China International
Capital Corporation
Limited
5 August
2022
Ordinary
shares
Hedging as a result of the
creation of new index-tracking
ETFs where the relevant
securities represent less than
1% of the class in issue and
less than 20% of the value of
the securities in the basket or
index
Purchase 10,500 $376,392.0000 $36.5600 $35.5100

End

Public Disclosure Form

==> picture [71 x 43] intentionally omitted <==

Note:

China International Capital Corporation Limited is an exempt principal trader connected with the Offeror. Dealings were made for its own account.

The shares reported refer to A shares of Yankuang Energy Group Company Limited (600188.SH), and price per unit is in RMB.